Respiratory Pathology

On this page

🔬 Respiratory Pathology: The Lung's Battlefield Architecture

The lungs stand at the crossroads of every breath and every bloodstream, making respiratory pathology a high-stakes discipline where architectural disruption, inflammatory cascades, and systemic ripple effects converge. You'll master how to recognize disease patterns through cellular and structural clues, systematically narrow differential diagnoses, and deploy evidence-based treatments that account for the lung's intimate dialogue with other organ systems. This lesson transforms you from observer to diagnostic detective, building the clinical precision needed when every breath counts.

Respiratory pathology encompasses the systematic study of lung diseases affecting 300 million alveoli, each measuring 0.2-0.3 mm in diameter. The respiratory system processes 12,000-15,000 liters of air daily, making it uniquely vulnerable to airborne pathogens, environmental toxins, and systemic inflammatory processes. Understanding pathological patterns requires mastering normal architecture first-from the conducting airways (generations 0-16) to the respiratory zone (generations 17-23).

📌 Remember: RAPID for major pathological categories - Restrictive diseases, Airway obstruction, Pleural disorders, Infections, Diffuse alveolar damage

The lung's dual blood supply creates unique pathological vulnerabilities. Pulmonary circulation (low pressure, 25/8 mmHg) handles gas exchange, while bronchial circulation (systemic pressure, 120/80 mmHg) supplies airways and pleura. This arrangement explains why pulmonary edema typically affects alveoli first, while bronchial artery bleeding causes massive hemoptysis.

⭐ Clinical Pearl: 95% of lung cancers arise from bronchial epithelium supplied by bronchial circulation, explaining why early tumors rarely cause gas exchange abnormalities

Cellular defense mechanisms operate at multiple levels. Alveolar macrophages clear 90% of inhaled particles >0.5 μm, while mucociliary escalator removes particles from conducting airways at 1-2 cm/minute. When these defenses fail, pathological processes follow predictable patterns based on particle size, toxicity, and host response.

Pathological CategoryPrimary LocationKey Cells InvolvedTypical TimelineReversibilityMortality Risk
Acute PneumoniaAlveolar spacesNeutrophils, macrophages1-7 daysHigh (>90%)5-15%
Interstitial FibrosisAlveolar wallsFibroblasts, type II pneumocytesMonths-yearsLow (<20%)30-50%
Airway ObstructionBronchi/bronchiolesEosinophils, smooth muscleMinutes-hoursModerate (60-80%)2-5%
Pleural DiseasePleural spaceMesothelial cellsDays-weeksVariable10-40%
Vascular DiseasePulmonary vesselsEndothelial cellsMinutes-daysModerate15-30%
  • Acute Inflammatory Response

    • Neutrophil recruitment within 2-4 hours
    • Peak inflammatory mediators at 24-48 hours
      • IL-1β increases 10-fold in pneumonia
      • TNF-α peaks at 6-12 hours post-injury
    • Resolution phase begins 72-96 hours with macrophage activation
  • Chronic Inflammatory Patterns

    • Fibroblast proliferation after 7-14 days
    • Collagen deposition peaks at 3-4 weeks
      • Type I collagen increases 300-500% in fibrosis
      • Type III collagen appears first, replaced by type I

Understanding respiratory pathology transforms clinical reasoning from symptom-based guessing to mechanism-based diagnosis, where tissue patterns predict disease progression and treatment response.

🔬 Respiratory Pathology: The Lung's Battlefield Architecture

⚡ Inflammatory Cascades: The Cellular Storm Command

Loading diagram…

📌 Remember: DAMP-TLR sequence - Damage signals, Activate TLRs, Mobilize neutrophils, Produce cytokines, Trigger resolution, Limit damage, Repair tissue

Complement cascade activation occurs within 30-60 seconds of tissue injury. C3a and C5a fragments increase vascular permeability by 200-300%, while C5a attracts neutrophils with 10-fold greater potency than other chemotactic factors. Membrane attack complex (C5b-9) formation causes direct cellular damage in 15-30 minutes.

  • Early Phase Response (0-4 hours)

    • Histamine release peaks at 5-15 minutes
    • Prostaglandin E2 increases 50-fold within 30 minutes
      • Causes bronchodilation and increased mucus production
      • Half-life of 2-3 minutes requires continuous synthesis
    • Leukotriene B4 peaks at 1-2 hours
      • 100-fold more potent than histamine for neutrophil chemotaxis
      • Triggers 5-10 fold increase in vascular permeability
  • Intermediate Phase (4-24 hours)

    • IL-1β and TNF-α peak at 6-12 hours
    • Neutrophil elastase activity increases 20-fold
      • Degrades elastin and collagen IV in basement membranes
      • Inactivated by α1-antitrypsin (deficiency causes emphysema)
    • Reactive oxygen species production peaks at 8-16 hours

⭐ Clinical Pearl: Neutrophil-to-lymphocyte ratio >10 predicts severe inflammatory response with 85% sensitivity for ARDS development

Inflammatory MediatorPeak TimePrimary EffectClinical MarkerTherapeutic TargetNormal vs Disease
Histamine5-15 minVasodilationFlushing, hypotensionH1/H2 blockers<1 vs 10-50 ng/mL
TNF-α6-12 hoursEndothelial activationFever, shockAnti-TNF agents<5 vs 50-500 pg/mL
IL-612-24 hoursAcute phase responseCRP elevationTocilizumab<7 vs 100-1000 pg/mL
IL-1024-48 hoursAnti-inflammatoryResolution markerSupportive<10 vs 50-200 pg/mL
TGF-β3-7 daysFibroblast activationFibrosis riskPirfenidone<25 vs 100-500 pg/mL

💡 Master This: Early intervention window exists in first 4-6 hours before neutrophil tissue damage becomes irreversible-explaining why corticosteroids work in early ARDS but fail after 24-48 hours

Resolution pathways activate through specialized pro-resolving mediators (SPMs). Lipoxin A4 production begins at 24-48 hours, promoting neutrophil apoptosis and macrophage efferocytosis. Resolvin E1 peaks at 72-96 hours, switching macrophages from M1 (pro-inflammatory) to M2 (anti-inflammatory) phenotype.

Understanding inflammatory timing enables precise therapeutic intervention, where anti-inflammatory agents work early, pro-resolution therapies work late, and antifibrotic agents prevent chronic complications.

⚡ Inflammatory Cascades: The Cellular Storm Command

🎯 Pattern Recognition: The Diagnostic Detective's Arsenal

Histological pattern recognition follows systematic architectural analysis. Alveolar patterns show airspace filling, interstitial patterns affect alveolar walls, and bronchiolar patterns involve small airways. Each pattern predicts specific disease categories with 80-95% accuracy when combined with clinical context.

📌 Remember: HAIL for CT patterns - Honeycombing (end-stage fibrosis), Air trapping (obstruction), Infiltrates (infection/inflammation), Lines (early fibrosis)

  • Alveolar Filling Patterns

    • Acute pneumonia: Neutrophil infiltration with >90% alveolar involvement
    • Pulmonary edema: Protein-rich fluid with <5% cellular content
      • Hydrostatic edema: Protein concentration <3 g/dL
      • Permeability edema: Protein concentration >4 g/dL
    • Alveolar hemorrhage: >20% hemosiderin-laden macrophages
      • Fresh bleeding shows red blood cells in >50% of alveoli
      • Chronic bleeding demonstrates hemosiderin in >30% of macrophages
  • Interstitial Thickening Patterns

    • Usual interstitial pneumonia: Temporal heterogeneity with fibroblastic foci
    • Nonspecific interstitial pneumonia: Uniform inflammation without honeycombing
      • Cellular NSIP: >50% inflammatory cells, <20% fibrosis
      • Fibrotic NSIP: >50% fibrosis, <20% inflammatory cells
    • Hypersensitivity pneumonitis: Centrilobular granulomas with giant cells
Loading diagram…

Radiological-pathological correlation requires understanding tissue density relationships. Ground-glass opacity represents partial alveolar filling or minimal interstitial thickening, while consolidation indicates complete alveolar filling. Reticular patterns suggest interstitial fibrosis with >2mm septal thickening.

CT PatternHistological CorrelateDisease AssociationReversibilityPrognosisTreatment Response
Ground-glassPartial alveolar fillingEarly inflammationHigh (>80%)GoodExcellent
ConsolidationComplete alveolar fillingPneumonia, edemaModerate (60%)VariableGood
HoneycombingEnd-stage fibrosisUIP, advanced ILDNone (0%)PoorMinimal
Tree-in-budBronchiolar inflammationInfection, aspirationHigh (>90%)GoodExcellent
Mosaic attenuationAir trappingSmall airway diseaseModerate (50%)VariableModerate

Temporal evolution patterns provide diagnostic clues. Acute processes (<4 weeks) show ground-glass or consolidation, subacute processes (4-12 weeks) develop reticular patterns, and chronic processes (>12 weeks) progress to honeycombing or traction bronchiectasis.

  • Infection Patterns

    • Bacterial pneumonia: Lobar consolidation with air bronchograms
    • Viral pneumonia: Bilateral ground-glass with peripheral distribution
      • COVID-19: Posterior and lower lobe predominance in >80%
      • Influenza: Centrilobular nodules with tree-in-bud pattern
    • Fungal infection: Nodules with halo sign or cavitation
      • Aspergillosis: Halo sign in >70% of immunocompromised patients
      • Mucormycosis: Reverse halo sign with vessel invasion
  • Inflammatory Patterns

    • Organizing pneumonia: Peripheral consolidation with migratory pattern
    • Hypersensitivity pneumonitis: Centrilobular nodules with mosaic attenuation
      • Acute HP: Ground-glass in >90% with upper lobe predominance
      • Chronic HP: Fibrosis with honeycombing in lower lobes

💡 Master This: Pattern + distribution + timeline = diagnosis. Peripheral + lower lobe + chronic suggests UIP, while central + upper lobe + subacute indicates hypersensitivity pneumonitis

Understanding pattern recognition transforms radiological interpretation from descriptive reporting to predictive diagnosis, enabling early intervention before irreversible changes develop.

🎯 Pattern Recognition: The Diagnostic Detective's Arsenal

🔍 Differential Diagnosis: The Systematic Discrimination Matrix

Systematic discrimination begins with anatomical localization. Upper lobe diseases include silicosis, hypersensitivity pneumonitis, and Langerhans cell histiocytosis. Lower lobe diseases encompass usual interstitial pneumonia, asbestosis, and drug-induced pneumonitis. Bilateral involvement suggests systemic processes, while unilateral patterns indicate localized pathology.

📌 Remember: UPPER for upper lobe diseases - Usual suspects (silicosis), Pneumoconiosis, Post-radiation, Eosinophilic granuloma, Respiratory bronchiolitis

  • Bilateral Infiltrate Discrimination
    • Cardiogenic pulmonary edema: Central distribution with Kerley B lines
      • BNP >400 pg/mL in >90% of cases
      • Pulmonary capillary wedge pressure >18 mmHg
      • Response to diuretics within 2-4 hours
    • ARDS: Peripheral distribution with bilateral involvement
      • PaO2/FiO2 ratio <300 (mild), <200 (moderate), <100 (severe)
      • Pulmonary capillary wedge pressure <18 mmHg
      • Protein-rich edema with >4 g/dL concentration
    • Pneumocystis pneumonia: Perihilar ground-glass with sparing of periphery
      • LDH >500 U/L in >95% of cases
      • CD4 count <200 cells/μL in HIV patients
      • β-D-glucan >80 pg/mL with >85% sensitivity
Loading diagram…

Cavitary lesion discrimination requires understanding wall thickness and surrounding changes. Thin-walled cavities (<4mm) suggest infectious causes, while thick-walled cavities (>4mm) indicate malignancy or necrotizing infection. Multiple cavities point to septic emboli, Wegener's granulomatosis, or metastatic disease.

Cavitary PatternWall ThicknessNumberLocationAssociated FindingsMost Likely Cause
Thin-walled<4mmSingleAny lobeAir-fluid levelLung abscess
Thick-walled>4mmSingleUpper lobeSpiculated marginsSquamous cell CA
Multiple thin<4mm>3 lesionsBilateralFeeding vessel signSeptic emboli
Multiple thick>4mm>3 lesionsRandomNodular patternMetastases
IrregularVariable1-3 lesionsUpper lobeSaddle nose, sinusitisWegener's
  • Solitary Pulmonary Nodule Discrimination
    • Benign characteristics: Smooth margins, central calcification, <6mm size
      • Doubling time >400 days suggests benign process
      • Popcorn calcification pathognomonic for hamartoma
      • Fat density on CT diagnostic for lipoma
    • Malignant characteristics: Spiculated margins, >8mm size, upper lobe location
      • Doubling time 30-400 days suggests malignancy
      • PET SUV >2.5 indicates >85% malignancy probability
      • Ground-glass component suggests adenocarcinoma

Interstitial pattern discrimination focuses on distribution and associated features. Usual interstitial pneumonia shows subpleural and basilar predominance with honeycombing. Nonspecific interstitial pneumonia demonstrates symmetric involvement without temporal heterogeneity. Hypersensitivity pneumonitis exhibits upper lobe predominance with centrilobular nodules.

  • Fibrotic Pattern Analysis
    • UIP pattern: Subpleural honeycombing with traction bronchiectasis
      • Lower lobe predominance in >95% of cases
      • Temporal heterogeneity with fibroblastic foci
      • Median survival 3-5 years without treatment
    • NSIP pattern: Bilateral lower lobe involvement without honeycombing
      • Ground-glass and reticular patterns mixed
      • Better prognosis with 5-year survival >80%
      • Steroid responsive in >70% of cases
    • Organizing pneumonia: Peripheral consolidation with migratory pattern
      • Excellent steroid response in >90% of cases
      • Complete resolution possible in >80%
      • Recurrence rate 15-20% after steroid withdrawal

💡 Master This: Distribution + timeline + steroid response discriminates fibrotic patterns. UIP = subpleural + chronic + steroid-resistant, NSIP = bilateral + subacute + steroid-responsive

Understanding systematic discrimination enables rapid differential narrowing, where pattern recognition combined with clinical context yields >90% diagnostic accuracy before invasive procedures.

🔍 Differential Diagnosis: The Systematic Discrimination Matrix

⚖️ Treatment Algorithms: Evidence-Based Therapeutic Command

Evidence-based treatment algorithms integrate severity assessment, pathophysiological mechanisms, and therapeutic targets. ARDS management follows lung-protective ventilation with tidal volumes 6 mL/kg, PEEP titration based on FiO2 requirements, and prone positioning for PaO2/FiO2 <150.

Loading diagram…

📌 Remember: ARDS-Net protocol - ARDS recognition, Respiratory rate <35, Driving pressure <15, Sedation minimized, Neuromuscular blockade if severe, ECMO if refractory, Tidal volume 6 mL/kg

  • Mechanical Ventilation Strategies
    • Lung-protective ventilation: Tidal volume 6 mL/kg predicted body weight
      • Plateau pressure <30 cmH2O to prevent volutrauma
      • Driving pressure <15 cmH2O associated with improved survival
      • Respiratory rate 20-35/min to maintain pH >7.25
    • PEEP titration: Higher PEEP for moderate-severe ARDS
      • PEEP 10-15 cmH2O for FiO2 0.5-0.8
      • PEEP >15 cmH2O for FiO2 >0.8
      • Recruitment maneuvers if P/F ratio <150
    • Prone positioning: >12 hours daily for severe ARDS
      • Mortality reduction 16% in severe cases
      • Improved V/Q matching within 2-4 hours
      • Contraindications: unstable spine, increased ICP

Pharmacological interventions target specific pathophysiological mechanisms. Corticosteroids reduce inflammation when given early (<72 hours), neuromuscular blockade improves ventilator synchrony in severe cases, and inhaled nitric oxide provides selective pulmonary vasodilation.

InterventionIndicationDosingDurationMonitoringSuccess Rate
MethylprednisoloneEarly ARDS1-2 mg/kg/day7-14 daysGlucose, infection60-70%
CisatracuriumSevere ARDS15 mg/hour48 hours maxTOF monitoring75-85%
Inhaled NOSevere hypoxemia5-20 ppm<7 daysMetHb levels50-60%
ECMORefractory ARDSFlow 3-5 L/minWeeksACT, hemolysis40-60%
Prone positioningP/F <150>12 hours/dayUntil improvementPressure sores70-80%
  • Interstitial Lung Disease Treatment
    • Idiopathic pulmonary fibrosis: Antifibrotic therapy with pirfenidone or nintedanib
      • Pirfenidone 2403 mg/day reduces FVC decline by 50%
      • Nintedanib 300 mg/day slows progression by 68%
      • Combination therapy under investigation
    • Inflammatory ILDs: Immunosuppressive therapy with corticosteroids
      • Prednisone 0.5-1 mg/kg/day for 4-6 weeks
      • Taper by 10-20% weekly based on response
      • Steroid-sparing agents: methotrexate, azathioprine
    • Hypersensitivity pneumonitis: Antigen avoidance plus anti-inflammatory therapy
      • Complete antigen removal essential for recovery
      • Corticosteroids for acute exacerbations
      • Antifibrotic therapy for fibrotic HP

Infection management follows antimicrobial stewardship principles. Community-acquired pneumonia treatment uses severity scores (CURB-65, PSI) to guide antibiotic selection and hospitalization decisions. Healthcare-associated pneumonia requires broad-spectrum coverage with de-escalation based on culture results.

  • Pneumonia Treatment Algorithms
    • Outpatient CAP: Amoxicillin 1g TID or macrolide for 5-7 days
      • CURB-65 score 0-1 predicts <3% mortality
      • Doxycycline alternative for β-lactam allergy
    • Inpatient CAP: β-lactam plus macrolide or respiratory fluoroquinolone
      • Ceftriaxone 1g daily plus azithromycin 500mg daily
      • Levofloxacin 750mg daily monotherapy alternative
      • Duration 5-7 days for uncomplicated cases
    • Severe CAP: β-lactam plus macrolide or β-lactam plus fluoroquinolone
      • ICU admission for CURB-65 ≥3 or PSI class V
      • MRSA coverage if risk factors present
      • Pseudomonas coverage for structural lung disease

💡 Master This: Severity assessment drives treatment intensity-CURB-65 ≥2 requires hospitalization, ≥3 suggests ICU consideration, and ≥4 predicts >25% mortality without aggressive intervention

Understanding evidence-based algorithms transforms treatment from empirical guessing to precision medicine, where biomarker-guided therapy and severity-stratified protocols optimize outcomes while minimizing adverse effects.

⚖️ Treatment Algorithms: Evidence-Based Therapeutic Command

🔗 Multi-System Integration: The Respiratory-Systemic Network

Cardiopulmonary integration demonstrates bidirectional pathophysiology. Pulmonary vascular disease increases right ventricular afterload, leading to cor pulmonale in >60% of patients with severe COPD. Left heart failure causes pulmonary venous hypertension, resulting in interstitial edema and secondary pulmonary hypertension.

📌 Remember: HEART-LUNG connections - Hypertension (pulmonary), Edema (cardiogenic), Arrhythmias (hypoxia), Right failure (cor pulmonale), Thromboembolism, Left failure (backward), Unloading (preload), Neurohormonal activation, Gas exchange impairment

  • Pulmonary Hypertension Classifications
    • Group 1 (PAH): Mean PAP >20 mmHg with PCWP ≤15 mmHg
      • Pulmonary vascular resistance >3 Wood units
      • Survival 65% at 3 years without treatment
      • Targeted therapy improves 6-minute walk distance by 30-50 meters
    • Group 2 (Left heart disease): PCWP >15 mmHg with elevated PAP
      • Most common cause of pulmonary hypertension (>80%)
      • Treatment focuses on underlying left heart disease
      • Pulmonary vasodilators may worsen left heart failure
    • Group 3 (Lung disease): Chronic hypoxemia with pulmonary vasoconstriction
      • Oxygen therapy if PaO2 <55 mmHg or SaO2 <88%
      • Survival benefit with >15 hours daily oxygen use
      • Lung transplantation for end-stage disease

Immunological integration reveals how systemic autoimmune diseases target pulmonary tissues. Rheumatoid arthritis causes interstitial pneumonia in 10-20% of patients, systemic sclerosis leads to pulmonary fibrosis in >70%, and ANCA-associated vasculitis produces pulmonary hemorrhage in 45-60%.

Loading diagram…
  • Connective Tissue Disease Manifestations
    • Systemic sclerosis: NSIP pattern in >70% with lower lobe predominance
      • Anti-Scl-70 antibodies predict severe fibrosis
      • Cyclophosphamide slows FVC decline by 2-3% annually
      • Autologous stem cell transplant for severe cases
    • Rheumatoid arthritis: UIP pattern more common than NSIP
      • Male predominance unlike joint disease
      • Methotrexate may worsen pulmonary fibrosis
      • Anti-CCP antibodies correlate with ILD risk
    • Sjögren's syndrome: Lymphocytic interstitial pneumonia characteristic
      • Cystic changes in >50% of cases
      • Lymphoma risk increased 40-fold
      • Rituximab effective for severe cases
CTDILD PrevalenceTypical PatternAntibody AssociationTreatment ResponsePrognosis
Systemic Sclerosis70-80%NSIPAnti-Scl-70ModerateVariable
Rheumatoid Arthritis10-20%UIPAnti-CCPPoorPoor
Polymyositis/DM30-50%NSIP/OPAnti-Jo-1GoodGood
Sjögren's10-20%LIPAnti-Ro/LaModerateGood
SLE5-10%AIPAnti-RNPGoodGood

Metabolic integration connects respiratory failure with systemic metabolic derangements. Chronic hypercapnia causes renal bicarbonate retention, chronic hypoxemia triggers erythropoietin production, and respiratory acidosis affects drug metabolism and electrolyte balance.

  • Systemic Effects of Respiratory Disease
    • Chronic hypoxemia: Polycythemia with hematocrit >55%
      • Erythropoietin levels increase 5-10 fold
      • Increased blood viscosity raises thrombosis risk
      • Phlebotomy if symptoms of hyperviscosity
    • Chronic hypercapnia: Compensated respiratory acidosis
      • Bicarbonate retention maintains pH 7.35-7.40
      • Chloride depletion from renal compensation
      • Avoid rapid CO2 correction (risk of metabolic alkalosis)
    • Pulmonary cachexia: Weight loss >10% in advanced COPD
      • Increased energy expenditure from work of breathing
      • Systemic inflammation with elevated TNF-α
      • Nutritional support improves respiratory muscle strength

💡 Master This: Respiratory-systemic crosstalk means lung disease affects every organ system-hypoxemia impairs cognitive function, hypercapnia causes somnolence, and chronic inflammation accelerates cardiovascular disease

Understanding multi-system integration transforms respiratory medicine from organ-specific treatment to comprehensive care, where systemic manifestations guide therapeutic priorities and comorbidity management determines overall outcomes.

🔗 Multi-System Integration: The Respiratory-Systemic Network

🎯 Clinical Mastery Arsenal: Rapid-Fire Diagnostic Precision

Essential Diagnostic Thresholds form the foundation of rapid clinical decision-making. ARDS severity stratifies by PaO2/FiO2 ratios: mild >200, moderate 100-200, severe <100. Pulmonary embolism probability increases with Wells score >4, D-dimer >500 ng/mL, and right heart strain on echocardiography.

📌 Remember: CRITICAL-5 thresholds - CO2 retention >50 mmHg, Respiratory rate >30, Infiltrates bilateral, Tidal volume <6 mL/kg, Inspiratory pressure >30, Compliance <40, Acidosis pH <7.25, Lactate >4 mmol/L

  • Rapid Assessment Framework
    • Oxygenation status: PaO2/FiO2 ratio determines ARDS severity
      • >300: Normal or mild impairment
      • 200-300: Moderate impairment (consider CPAP)
      • 100-200: Severe impairment (requires intubation)
      • <100: Critical impairment (ECMO consideration)
    • Ventilation status: PaCO2 and pH guide ventilator settings
      • PaCO2 >50 mmHg: Increase minute ventilation
      • pH <7.25: Respiratory acidosis requires immediate intervention
      • Driving pressure >15 cmH2O: Lung injury risk
    • Hemodynamic status: Right heart strain suggests pulmonary vascular disease
      • RV/LV ratio >1.0 on CT indicates acute cor pulmonale
      • Tricuspid regurgitation velocity >3.4 m/s suggests pulmonary hypertension
      • BNP >400 pg/mL differentiates cardiogenic from non-cardiogenic edema
Clinical ScenarioKey ThresholdImmediate ActionTime FrameSuccess MarkerFailure Backup
Severe ARDSP/F ratio <100Prone positioning<6 hoursP/F improvement >20%ECMO consultation
Massive PERV/LV >1.5Thrombolysis<90 minutesHemodynamic stabilityEmbolectomy
Tension PTXTracheal deviationNeedle decompression<5 minutesBreath sounds returnChest tube
Status asthmaticusPeak flow <25%High-dose β-agonists<30 minutesPeak flow >50%Intubation
Acute exacerbationpH <7.25NIV + steroids<2 hourspH >7.30Intubation

Pattern Recognition Shortcuts enable instant diagnosis. Bilateral infiltrates + normal heart size + acute onset = ARDS. Unilateral infiltrate + fever + productive cough = pneumonia. Peripheral infiltrates + eosinophilia + migratory pattern = organizing pneumonia.

  • Imaging Pattern Mastery
    • Ground-glass opacity: Early inflammatory process
      • Reversible in >80% of cases
      • Steroid responsive if inflammatory
      • Progression to fibrosis if untreated
    • Honeycombing: End-stage fibrosis
      • Irreversible structural change
      • Transplant evaluation indicated
      • Median survival 3-5 years
    • Tree-in-bud: Infectious bronchiolitis
      • Antibiotic responsive in >90%
      • Complete resolution expected
      • Recurrence suggests underlying cause

Therapeutic Decision Trees streamline treatment selection. Inflammatory markers guide steroid timing: CRP >100 mg/L suggests bacterial infection (avoid steroids), CRP 20-50 mg/L with lymphocytosis indicates viral or inflammatory process (consider steroids).

Loading diagram…

💡 Master This: Time-sensitive interventions save lives-early recognition + rapid implementation + continuous monitoring = optimal outcomes. Delayed treatment exponentially increases mortality risk in respiratory emergencies

Understanding rapid diagnostic precision transforms emergency respiratory care from reactive management to proactive intervention, where pattern recognition and threshold-based decisions enable life-saving treatment within critical time windows.

🎯 Clinical Mastery Arsenal: Rapid-Fire Diagnostic Precision

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

Practice Questions: Respiratory Pathology

  1. 1. A 28-year-old woman having limited cutaneous scleroderma for the last 10 years complains of shortness of breath for the last one month. Pulmonary function tests (PFT) are as follows. What is the most likely diagnosis in this case?

    • A. Interstitial lung disease
    • B. Pulmonary hypertension
    • C. Pulmonary bronchiectasis
    • D. Congestive heart failure
    Show answer

    Answer: B. Pulmonary hypertension

    Pulmonary hypertension is most likely because longstanding limited cutaneous systemic sclerosis with DLCO 50% predicted and preserved spirometry and TLC suggests pulmonary vascular disease, although PFTs alone do not confirm it. Pulmonary bronchiectasis often causes airflow obstruction but can have normal spirometry; an isolated diffusion defect is less characteristic. Congestive heart failure can reduce DLCO with normal or restricted volumes, but this clinical context more strongly favors pulmonary vascular disease. Interstitial lung disease may initially reduce DLCO before restriction develops, so normal TLC does not exclude early disease; the isolated diffusion defect in longstanding limited cutaneous systemic sclerosis nevertheless favors pulmonary hypertension.

  2. 2. Which feature is NOT associated with chronic granulomatous disease?

    • A. Recurrent staphylococcal infections
    • B. Defective intracellular oxidative killing
    • C. Autosomal dominant inheritance
    • D. Abnormal nitroblue tetrazolium test
    Show answer

    Answer: C. Autosomal dominant inheritance

    Autosomal dominant inheritance is the exception: CGD is classically X-linked recessive or autosomal recessive. Defective intracellular oxidative killing is characteristic because NADPH oxidase activity is impaired, although microbial ingestion is preserved. Recurrent staphylococcal infections occur because Staphylococcus aureus is a characteristic catalase-positive pathogen in CGD. An abnormal nitroblue tetrazolium test reflects impaired oxidative burst and is a traditional screening finding, although dihydrorhodamine flow cytometry is now preferred.

  3. 3. A 60-year-old man presents with progressive exertional dyspnea. HRCT shows basal and subpleural-predominant reticulation, traction bronchiectasis, and clustered honeycomb cysts, with heterogeneous involvement. There is no predominant ground-glass opacity, consolidation, nodularity, significant air trapping, or hilar lymphadenopathy. ANA is weakly positive at 1:80, but there are no clinical features of connective-tissue disease. Which diagnosis best describes the HRCT pattern?

    • A. Cryptogenic organizing pneumonia
    • B. Pulmonary sarcoidosis
    • C. Usual interstitial pneumonia
    • D. Nonspecific interstitial pneumonia
    Show answer

    Answer: C. Usual interstitial pneumonia

    Usual interstitial pneumonia - The basal, subpleural-predominant honeycombing with traction bronchiectasis and heterogeneous fibrosis meets the standard HRCT description of a UIP pattern. Isolated low-titre ANA positivity does not establish CTD-associated ILD or favor NSIP over a characteristic UIP pattern. This identifies UIP morphology, not necessarily idiopathic pulmonary fibrosis; the latter additionally requires exclusion of identifiable causes. Nonspecific interstitial pneumonia - NSIP usually shows predominant ground-glass opacity and fine reticulation, often with relative subpleural sparing; substantial honeycombing is uncommon but possible. Cryptogenic organizing pneumonia - COP typically shows patchy peripheral or peribronchovascular consolidation rather than this fibrotic pattern. Pulmonary sarcoidosis - Fibrotic sarcoidosis can produce honeycombing, but usually has upper/perihilar-predominant fibrosis and associated nodal or perilymphatic abnormalities rather than the basal subpleural pattern described.

  4. 4. A 35-year-old woman with a long history of dyspnea, chronic cough, sputum production, and wheezing dies of respiratory failure following a bout of lobar pneumonia. She had never smoked. Which of the following underlying conditions is most likely associated with the pathologic changes shown in the lung autopsy?

    • A. Cystic fibrosis
    • B. Anti-glomerular basement membrane disease
    • C. Primary ciliary dyskinesia
    • D. Alpha-1 antitrypsin deficiency
    Show answer

    Answer: D. Alpha-1 antitrypsin deficiency

    Alpha-1 antitrypsin deficiency is the best answer because the image shows emphysema in a young lifelong nonsmoker. Deficient antiprotease activity permits elastase-mediated alveolar destruction; this disorder characteristically causes panacinar emphysema, although the supplied image does not establish lobar distribution. Cystic fibrosis predominantly causes mucus plugging, recurrent infection and bronchiectasis. Anti-glomerular basement membrane disease causes pulmonary haemorrhage, often with glomerulonephritis, rather than emphysema. Primary ciliary dyskinesia causes impaired mucociliary clearance and bronchiectasis rather than the emphysematous destruction shown.

  5. 5. What is the probable diagnosis in the patient with the provided flow volume loop (FVL)?

    • A. Lower airway obstructive disease
    • B. Fixed upper airway obstruction
    • C. Restrictive ventilatory defect
    • D. Variable extrathoracic obstruction
    Show answer

    Answer: B. Fixed upper airway obstruction

    Fixed upper airway obstruction - Flattening of both the inspiratory and expiratory limbs produces a characteristic box-shaped flow-volume loop, indicating fixed upper airway obstruction. - A lesion such as tracheal stenosis causes fixed anatomical narrowing that limits maximal airflow regardless of respiratory effort. Lower airway obstructive disease - Obstructive airway disease typically produces a scooped-out, concave expiratory limb from dynamic airway collapse, rather than flattening of both limbs. - It is associated with reduced peak expiratory flow and a prolonged expiratory phase, contrasting with the loop’s fixed plateau pattern. Restrictive ventilatory defect - Restrictive airway disease generally preserves the normal flow-volume loop contour while reducing FVC and TLC, rather than creating plateaus. - The curve appears smaller with reduced volumes but maintains its shape, unlike the flattened inspiratory and expiratory limbs shown here. Variable extrathoracic obstruction - Variable extrathoracic obstruction predominantly flattens the inspiratory limb, whereas the supplied loop shows flattening of both limbs.

  6. 6. Chemotaxis is mediated by-

    • A. Histamine and serotonin
    • B. Bradykinin and prostaglandin E2
    • C. Leukotriene C4 and C3a
    • D. Leukotriene B4 and C5a
    Show answer

    Answer: D. Leukotriene B4 and C5a

    Leukotriene B4 and C5a - Leukotriene B4 and C5a are potent chemoattractants that direct neutrophils and other leukocytes toward sites of inflammation. - These mediators amplify the acute inflammatory response by promoting leukocyte recruitment, making them appropriate mediators of chemotaxis. Histamine and serotonin - Histamine and serotonin mainly mediate vascular responses rather than the potent directed leukocyte migration associated with LTB4 and C5a Bradykinin and prostaglandin E2 - Bradykinin and prostaglandin E2 chiefly contribute to pain and vascular responses rather than serving as the classic potent chemoattractants tested here Leukotriene C4 and C3a - Leukotriene C4 primarily causes bronchoconstriction, while C3a participates in complement-mediated inflammation but is less potent in chemotaxis than C5a. - These mediators have different principal functions and lack the strong leukocyte-attracting activity characteristic of LTB4 and C5a.

  7. 7. Which of the following is NOT a typical clinical feature of bronchiectasis?

    • A. Chest pain
    • B. Productive cough
    • C. Hemoptysis
    • D. Night sweats
    Show answer

    Answer: D. Night sweats

    Night sweats is not a typical clinical feature of bronchiectasis, although it may occur with associated infection; prominent night sweats should prompt evaluation for another or additional cause. Chest pain - Chest pain can occur in bronchiectasis because persistent coughing causes musculoskeletal strain and associated inflammation may irritate the pleura. - Although not a defining symptom, chest pain may accompany infective exacerbations or inflammation extending toward the pleural tissues. Productive cough - A chronic productive cough containing substantial purulent sputum is the hallmark clinical symptom of bronchiectasis. - This results from impaired mucociliary clearance, persistent infection, and accumulation of secretions within dilated, damaged airways. Hemoptysis - Hemoptysis is a common clinical feature of bronchiectasis caused by inflammation and structural damage involving the bronchial walls and vessels. - Fragile bronchial blood vessels may rupture, producing blood-streaked sputum or, in severe cases, massive pulmonary haemorrhage.

  8. 8. Which of the following is NOT a standard management option for established fat embolism syndrome?

    • A. Supplemental oxygen
    • B. Hemodynamic support
    • C. Surgical intervention
    • D. Mechanical ventilation
    Show answer

    Answer: C. Surgical intervention

    Surgical intervention is not a standard treatment for established fat embolism syndrome, which is primarily managed with supportive care. Surgery may stabilize the initial long-bone fracture and help prevent further embolization, but it does not directly treat established fat embolism syndrome. Supplemental oxygen treats hypoxemia. Hemodynamic support maintains circulation when instability is present. Mechanical ventilation supports patients with severe respiratory failure.

  9. 9. Which of the following is NOT a typical differential diagnosis for a solitary pulmonary nodule?

    • A. Hamartoma
    • B. Mycetoma
    • C. Tuberculoma
    • D. Lung cancer
    Show answer

    Answer: B. Mycetoma

    Mycetoma - In this thoracic context, mycetoma denotes an intracavitary fungal ball, usually an aspergilloma; it should not be confused with subcutaneous mycetoma, which may be fungal or bacterial. - When involving the lung, it usually forms a fungus ball (aspergilloma) within a pre-existing cavity, so it is not a typical differential for a solitary pulmonary nodule. Lung cancer - Lung cancer is a primary malignant lung tumor and an important consideration when evaluating a solitary pulmonary nodule. - Its inclusion is appropriate because early detection of lung malignancy affects prognosis and treatment, particularly for adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Hamartoma - Hamartoma is a benign tumor-like malformation composed of disorganized normal tissues, including cartilage, fat, and muscle. - It is among the most common benign causes of a solitary pulmonary nodule and therefore belongs in the differential diagnosis. Tuberculoma - A tuberculoma is a granuloma caused by Mycobacterium tuberculosis and may appear as a well-defined solitary pulmonary nodule or mass. - It represents a contained form of pulmonary tuberculosis and is an important differential, especially in tuberculosis-endemic areas.

  10. 10. An adult with symptomatic pulmonary sarcoidosis requires initial systemic therapy and has no glucocorticoid contraindication. Which drug is first-line?

    • A. Methotrexate
    • B. Azathioprine
    • C. Infliximab
    • D. Prednisolone
    Show answer

    Answer: D. Prednisolone

    Prednisolone is the first-line systemic drug for symptomatic pulmonary sarcoidosis requiring treatment when glucocorticoids are suitable. Methotrexate is generally a steroid-sparing alternative rather than the initial choice in this setting. Azathioprine is another steroid-sparing immunosuppressant and is not the routine initial treatment here. Infliximab is generally reserved for refractory disease rather than initial systemic treatment.

Flashcards: Respiratory Pathology

  1. 1. In ARDS, activation of _____ by proinflammatory cytokines induces _____ and _____-mediated damage of _____ pneumocytes

    Show answer

    neutrophils · free radical · protease · both type I and II

  2. 2. _____ results in _____ emphysema that is most severe in the _____ lobes of the lung

    Show answer

    1-antitrypsin deficiency · panacinar · lower

  3. 3. Most pneumoconiosis involves the _____ lobes of the lung (coal worker's pneumoconiosis (CWP), silicosis, berylliosis), except _____

    Show answer

    upper · asbestosis

  4. 4. In acute respiratory distress syndrome (ARDS), tissue injury is caused mainly by .

    Show answer

    neutrophils::Immune cell

  5. 5. _____ pneumonia is characterized by diffuse, patchy inflammation that is localized to _____ areas at alveolar walls

    Show answer

    Atypical · interstitial

  6. 6. _____ is characterized by macrophages laden with _____, causing inflammation and fibrosis

    Show answer

    Coal workers' pneumoconiosis · carbon

  7. 7. Histopathology showing the _____ effect are suggestive of a _____ carcinoma of the lung.

    Show answer

    Azzopardi · small cell

  8. 8. _____ bodies are seen in cryptogenic organizing pneumonia.

    Show answer

    Masson

  9. 9. The diagnosis is _____ carcinoma of the lung.

    Show answer

    large cell

  10. 10. Asbestos bodies contain _____ and thus may be visualized using a _____ stain

    Show answer

    iron · Prussian blue

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF